D. Eskesen

University of Copenhagen

Health Outcomes Studied

• Improved Bowel Movement Frequency
• Increased Persistence of Probiotics in Fecal Matter
• Increased Salivary sIgA Levels
• Reduced Abdominal Pain

Papers (6)

• 2021
  Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial.10.3920/BM2021.0065
• 2015
  Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study.10.3945/ajcn.114.103531
• 2015Primary author
  Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial10.1017/S0007114515003347
• 2014
  The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12®10.3390/microorganisms2020092
• 2012
  Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.10.1017/S000711451100420X
• 2006
  Dose–response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults10.1038/sj.ejcn.1602450